Pandolfi, Pier Paolo
Renown Health,
United States
2025 Rank: 2271
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 139 out of 157999 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2271 | 2392 |
| Total Cites | 87341 | 94590 |
| H-index | 147 | 152 |
| Hm-index | 47 | 49 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 618 | 651 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1898 | 2087 |
| Number of Single+First+Last Authored Papers | 269 | 269 |
| Total Cites to Single+First+Last Authored Papers | 56012 | 59428 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 63162 | 66050 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.43 |
| Self-Citation Percentage |
7.66%
|
|
Pandolfi, Pier Paolo
Nevada System of Higher Education,
United States
2024 Rank: 2157
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 132 out of 149337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2157 | 2249 |
| Total Cites | 83064 | 90122 |
| H-index | 143 | 150 |
| Hm-index | 46 | 49 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 608 | 640 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1869 | 2055 |
| Number of Single+First+Last Authored Papers | 265 | 265 |
| Total Cites to Single+First+Last Authored Papers | 53197 | 56541 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 59780 | 62577 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.44 |
| Self-Citation Percentage |
7.83%
|
|
Pandolfi, Pier Paolo
Renown Health,
United States
2023 Rank: 2036
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 128 out of 138178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2036 | 2120 |
| Total Cites | 78465 | 85366 |
| H-index | 140 | 147 |
| Hm-index | 45 | 48 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 594 | 626 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1839 | 2020 |
| Number of Single+First+Last Authored Papers | 265 | 265 |
| Total Cites to Single+First+Last Authored Papers | 50034 | 53329 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 56121 | 58831 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.45 |
| Self-Citation Percentage |
8.08%
|
|
Pandolfi, Pier Paolo
Beth Israel Deaconess Medical Center,
United States
2022 Rank: 1938
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 124 out of 127685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1938 | 1964 |
| Total Cites | 72500 | 79174 |
| H-index | 134 | 143 |
| Hm-index | 45 | 47 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 581 | 613 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1784 | 1970 |
| Number of Single+First+Last Authored Papers | 262 | 262 |
| Total Cites to Single+First+Last Authored Papers | 45865 | 49074 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 51465 | 54073 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.46 |
| Self-Citation Percentage |
8.43%
|
|
Pandolfi, Pier Paolo
Harvard Medical School,
United States
2021 Rank: 1845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 131 out of 123644 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1845 | 1883 |
| Total Cites | 69574 | 76032 |
| H-index | 133 | 142 |
| Hm-index | 45 | 47 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 572 | 604 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1754 | 1937 |
| Number of Single+First+Last Authored Papers | 255 | 255 |
| Total Cites to Single+First+Last Authored Papers | 43857 | 46973 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 49222 | 51741 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
8.49%
|
|
Pandolfi, Pier Paolo
Harvard Medical School,
United States
2020 Rank: 1800
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 139 out of 105600 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1800 | 1821 |
| Total Cites | 62135 | 68287 |
| H-index | 127 | 136 |
| Hm-index | 43 | 45 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 561 | 593 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 1705 | 1893 |
| Number of Single+First+Last Authored Papers | 248 | 248 |
| Total Cites to Single+First+Last Authored Papers | 38542 | 41551 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 43512 | 45872 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.49 |
| Self-Citation Percentage |
9.01%
|
|